UBS lowers Baker Hughes stock price target to $70 on GTLS margins

UBS cut its Baker Hughes price target to $70 from $71 and retained a Neutral rating after Chart Industries (GTLS) issued weaker-than-expected guidance, chiefly on margins. Baker Hughes expects GTLS margins to rise from about 17% in 2H 2026 to 18.9% in FY2027 and 22.1% in FY2028, while UBS forecasts acquisition-related adjusted EPS accretion of 8.5% in FY2027 and 11.8% in FY2028. The $13.6 billion Chart acquisition supports longer-term earnings potential, but softer near-term GTLS performance tempered estimates; shares were trading at $60.80 versus UBS's $70 target.

Analysis

The relevant valuation question is no longer whether BKR can close the acquisition, but whether the acquired earnings can be rerated before the stated margin bridge is proven. A move from sub-19% to low-20% margins requires procurement, manufacturing and commercial synergies to arrive on schedule; until then, investors are underwriting an execution promise while absorbing near-term estimate reductions. That raises the likelihood that BKR trades on quarterly margin conversion and cash-flow delivery rather than on oil-price beta over the next 1-3 months.

BKR's portfolio is increasingly levered to LNG, industrial gas and power-equipment investment cycles, which should command a higher multiple than a pure North American oilfield-services company if backlog remains resilient. The second-order risk is that higher energy prices improve customer project economics but also raise equipment, freight and labor costs, delaying the very margin expansion needed to validate the transaction. SLB and HAL offer cleaner oilfield-service exposure; BKR should outperform them only if Gas Technology order growth and acquired-business margins surprise upward.

Consensus appears split between a near-term dilution narrative and a long-duration synergy narrative, creating a potentially attractive setup after the next formal combined-company guidance. The stock has already appreciated materially, however, so upside toward the higher sell-side valuation range is contingent on management quantifying synergy timing, capex needs and free-cash-flow conversion. A guidance reset, weaker-than-expected LNG/project orders, or failure to show sequential acquired-business margin improvement would falsify the rerating thesis quickly.

Key Decisions for Investors

• Maintain BKR as a watch-to-buy rather than chase: initiate a 1-2% long only on a pullback toward $57-59 or after formal guidance confirms 2027 accretion and cash-flow conversion. Target $70-76 over 6-12 months; exit on a sustained break below $55 or a reduction in the medium-term margin framework.
• For sector exposure, consider a 6-12 month long BKR / short HAL pair after combined guidance. The trade isolates BKR's gas, LNG and integration optionality against HAL's more direct North American completion-cycle sensitivity; close if BKR's acquired-business margin fails to improve sequentially for two reporting periods.
• Do not underwrite the stated long-term EPS accretion at face value until management discloses synergy run-rate, restructuring costs and working-capital requirements. Set an alert around the first post-close earnings call: a quantified synergy plan with unchanged leverage and FCF targets is the catalyst for adding risk.
• Use SLB or XLE, rather than BKR, for a tactical 1-3 month oil-price hedge. BKR's equity reaction to higher crude may be muted if investors focus on integration execution; a deterioration in LNG order intake or project cancellations would outweigh supportive upstream activity.